Data from clinical trials have suggested that short-term treatment with estrogen (<10 years) results in a reduced incidence of breast cancer, whereas long-term treatment (>20 years) is associated with an increased risk of breast cancer. The authors of this Viewpoint describe possible mechanisms to account for these seemingly paradoxical effects.
- Richard J Santen
- D Craig Allred
